Skip to main content

Advertisement

Table 2 Per-protocol analysis of chloroquine efficacy to treat P. vivax malaria in the Saharan zone in Mauritania

From: Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania

Outcome Nouakchott Atar
Number of enrolled patients 67 61
Exclusion after enrollment, n (%) 3 (4.5) 0
Lost-to-follow-up, n (%) 2 (3.0) 4 (6.6)
Per protocol population, n 62 57
PCR-uncorrected outcome*   
Early treatment failure, n (%) 0 0
Late clinical failure (LCF), n (%) 0 0
Late parasitological failure, n (%) 0 0
Adequate clinical and parasitological response, n (%) 62 (100) 57 (100)
  1. *PCR correction was not performed due to 100% efficacy (per protocol population) on day 28.